Niels Pacheco-Barrios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Niels Pacheco-Barrios has a total of 286 co-authors. Here are the top co-authors by number of shared publications:
Fritz Fidel Váscones-Román
Facultad de Medicina Humana, Universidad Peruana Cayetano Heredia, Lima, Perú
6 shared publicationsKarlos Acurio
School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru
6 shared publicationsAryan Wadhwa
Department of Neurosurgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
4 shared publications- Fritz Fidel Váscones-Román
Faculty of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America; Váscones's Lab, Lima, Peru
4 shared publications - Christopher S. Ogilvy
Neurosurgery, BIDMC, Boston, Massachusetts, USA
3 shared publications - Karlos Acurio
Astrocyte, Neurosurgical Research Group, Boston, MA, USA
3 shared publications
Latest Publications
- Open Access
- 26 July 2026
- Published by Instituto Peruano de Orientacion Psicologica - IPOPS in Interacciones
- p. e485
Video game–based interventions for depressive symptoms in adults: A systematic review and qualitative synthesis
Background: Depression is one of the most prevalent mental health disorders worldwide, and conventional treatments may face limitations related to accessibility, stigma, adherence, and variable response. Video game–based interventions, including serious games and commercially available off-the-shelf games, have emerged as potentially accessible and engaging tools for supporting mental health care. Objective: This systematic review aimed to evaluate the reported therapeutic effects of video game–based interventions on depressive symptoms in adults through a structured qualitative synthesis of the available evidence. Methods: A comprehensive search was conducted in PubMed, PsycINFO, Cochrane Library, Web of Science, and IEEE Xplore for studies published from January 2018 to January 2024, following PRISMA guidelines and a protocol registered in PROSPERO (CRD420251107133). Eligible studies included adult participants with a clinical diagnosis of depression or elevated depressive symptoms, evaluated video game–based interventions, and reported depressive symptom outcomes using validated or clearly defined psychological measures. Randomized controlled trials and non-randomized interventional studies were included. Risk of bias (RoB) was assessed using RoB 2 for randomized trials and ROBINS-I for non-randomized studies. Results: Of 2,038 records identified, 13 studies met the inclusion criteria. The included studies varied substantially in design, population, intervention type, platform, duration, comparator condition, and outcome measurement. Video game–based interventions were generally associated with improvements in depressive symptoms, while secondary outcomes included anxiety, emotional regulation, cognitive function, sleep quality, self-efficacy, and psychological well-being when reported. Common intervention types included casual games, exergames, role-playing games, mobile applications, and online games. However, methodological heterogeneity, small sample sizes in several studies, variable risk of bias, and limited follow-up reduced the comparability of findings and precluded quantitative synthesis. Conclusion: The available evidence suggests that video game–based interventions may be associated with improvements in depressive symptoms in adults. However, due to methodological heterogeneity, variable risk of bias, and the absence of meta-analysis, these findings should be interpreted with caution. Further adequately powered randomized controlled trials with standardized intervention reporting, validated depression outcomes, appropriate comparator groups, and long-term follow-up are needed to clarify their therapeutic role.
- 26 July 2026
- Published by Instituto Peruano de Orientacion Psicologica - IPOPS in Interacciones
- p. e485
Open AccessVideo game–based interventions for depressive symptoms in adults: A systematic review and qualitative synthesis
Background: Depression is one of the most prevalent mental health disorders worldwide, and conventional treatments may face limitations related to accessibility, stigma, adherence, and variable response. Video game–based interventions, including serious games and commercially available off-the-shelf games, have emerged as potentially accessible and engaging tools for supporting mental health care. Objective: This systematic review aimed to evaluate the reported therapeutic effects of video game–based interventions on depressive symptoms in adults through a structured qualitative synthesis of the available evidence. Methods: A comprehensive search was conducted in PubMed, PsycINFO, Cochrane Library, Web of Science, and IEEE Xplore for studies published from January 2018 to January 2024, following PRISMA guidelines and a protocol registered in PROSPERO (CRD420251107133). Eligible studies included adult participants with a clinical diagnosis of depression or elevated depressive symptoms, evaluated video game–based interventions, and reported depressive symptom outcomes using validated or clearly defined psychological measures. Randomized controlled trials and non-randomized interventional studies were included. Risk of bias (RoB) was assessed using RoB 2 for randomized trials and ROBINS-I for non-randomized studies. Results: Of 2,038 records identified, 13 studies met the inclusion criteria. The included studies varied substantially in design, population, intervention type, platform, duration, comparator condition, and outcome measurement. Video game–based interventions were generally associated with improvements in depressive symptoms, while secondary outcomes included anxiety, emotional regulation, cognitive function, sleep quality, self-efficacy, and psychological well-being when reported. Common intervention types included casual games, exergames, role-playing games, mobile applications, and online games. However, methodological heterogeneity, small sample sizes in several studies, variable risk of bias, and limited follow-up reduced the comparability of findings and precluded quantitative synthesis. Conclusion: The available evidence suggests that video game–based interventions may be associated with improvements in depressive symptoms in adults. However, due to methodological heterogeneity, variable risk of bias, and the absence of meta-analysis, these findings should be interpreted with caution. Further adequately powered randomized controlled trials with standardized intervention reporting, validated depression outcomes, appropriate comparator groups, and long-term follow-up are needed to clarify their therapeutic role.
- 29 June 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1)
Neurosurgical training in low- and middle-income countries: structural inequities, scalable solutions, and a Peruvian national case study
Neurosurgical workforce inequities remain a major barrier to timely access to essential neurosurgical care in low- and middle-income countries (LMICs). Because workforce capacity depends not only on the number of trainees but also on the quality, geographic distribution, and sustainability of training systems, neurosurgical training is a critical determinant of global neurosurgical equity. We aimed to synthesize the principal barriers and scalable solutions in neurosurgical training across LMICs and to illustrate these patterns through a national case study of adult neurosurgery residency positions in Peru. We conducted a structured narrative review of the literature on neurosurgical training in LMICs, focusing on historical development, residency training, mentorship, digital education, simulation, and international collaboration. In parallel, we performed a descriptive national case study of adult neurosurgery residency positions available in Peru in 2025, assessing their geographic and institutional distribution. Across the reviewed literature and the Peruvian national case study, barriers to neurosurgical training appeared to be predominantly related to structural and institutional factors, including geographic centralization, limited educational infrastructure, inconsistent subspecialty exposure, financial constraints, and unequal access to mentorship. This does not exclude the role of individual motivation or institutional culture, but suggests that trainee interest alone is insufficient to overcome system-level barriers. Promising scalable strategies included competency-based curricula, structured virtual learning, low-cost simulation models, and partnership frameworks centered on local capacity-building. In Peru, 31 adult neurosurgery residency positions were identified across 20 hospitals in 7 regions, with marked concentration in Lima and repeated clustering within a small number of high-complexity referral institutions. This distribution reflects a centralized training model with limited regional expansion. Neurosurgical training inequities in LMICs appear to be strongly shaped by the structural concentration of training capacity, although local institutional culture, trainee motivation, and national policy contexts may also influence access to high-quality training. Expanding the neurosurgical workforce will require coordinated national planning, investment in regional training hubs, and sustainable educational partnerships that strengthen local ownership and workforce sustainability.
- 29 June 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1)
Neurosurgical training in low- and middle-income countries: structural inequities, scalable solutions, and a Peruvian national case study
Neurosurgical workforce inequities remain a major barrier to timely access to essential neurosurgical care in low- and middle-income countries (LMICs). Because workforce capacity depends not only on the number of trainees but also on the quality, geographic distribution, and sustainability of training systems, neurosurgical training is a critical determinant of global neurosurgical equity. We aimed to synthesize the principal barriers and scalable solutions in neurosurgical training across LMICs and to illustrate these patterns through a national case study of adult neurosurgery residency positions in Peru. We conducted a structured narrative review of the literature on neurosurgical training in LMICs, focusing on historical development, residency training, mentorship, digital education, simulation, and international collaboration. In parallel, we performed a descriptive national case study of adult neurosurgery residency positions available in Peru in 2025, assessing their geographic and institutional distribution. Across the reviewed literature and the Peruvian national case study, barriers to neurosurgical training appeared to be predominantly related to structural and institutional factors, including geographic centralization, limited educational infrastructure, inconsistent subspecialty exposure, financial constraints, and unequal access to mentorship. This does not exclude the role of individual motivation or institutional culture, but suggests that trainee interest alone is insufficient to overcome system-level barriers. Promising scalable strategies included competency-based curricula, structured virtual learning, low-cost simulation models, and partnership frameworks centered on local capacity-building. In Peru, 31 adult neurosurgery residency positions were identified across 20 hospitals in 7 regions, with marked concentration in Lima and repeated clustering within a small number of high-complexity referral institutions. This distribution reflects a centralized training model with limited regional expansion. Neurosurgical training inequities in LMICs appear to be strongly shaped by the structural concentration of training capacity, although local institutional culture, trainee motivation, and national policy contexts may also influence access to high-quality training. Expanding the neurosurgical workforce will require coordinated national planning, investment in regional training hubs, and sustainable educational partnerships that strengthen local ownership and workforce sustainability.
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 17
CLINICAL OUTCOMES OF EARLY OR PRIMARY DECOMPRESSIVE CRANIECTOMY FOR TRAUMATIC BRAIN INJURY IN LATIN AMERICA: A SYSTEMATIC REVIEW
Background Early or primary decompressive craniectomy (DC) is widely used to treat intracranial hypertension after traumatic brain injury (TBI), yet its clinical benefit remains debated. In Latin America, outcomes may be influenced by heterogeneity in trauma systems, neurocritical care resources, neuromonitoring availability, and access to rehabilitation. Objective To systematically review the available evidence on clinical outcomes of early or primary decompressive craniectomy for adult traumatic brain injury in Latin America. Methods We conducted a systematic review in accordance with PRISMA 2020 guidance. PubMed/MEDLINE, Scopus, Embase, Web of Science, SciELO, and LILACS were searched from inception to December 10, 2025. We included studies from Latin American countries enrolling predominantly adult patients with TBI undergoing early or primary DC, with or without a medical-management comparator. Primary outcomes were favorable functional outcome (Glasgow Outcome Scale [GOS] 4–5) at hospital discharge and at approximately 6 months. Secondary outcomes included mortality at discharge among DCtreated patients and comparative mortality when a non-DC comparator was available. Given substantial clinical and methodological heterogeneity across studies, findings were synthesized narratively. Results Fourteen studies involving 1,816 patients with TBI were included, of whom 1,075 underwent early or primary DC. Most studies were retrospective observational cohorts or case series. Reported outcomes varied widely across studies. Favorable functional outcome at discharge ranged from 26% to 66% among studies reporting this endpoint, while favorable outcome at approximately 6 months ranged from 21% to 80%. Mortality at discharge among DC-treated patients also varied substantially, ranging from 0% to 61%. Only two studies reported comparative mortality between DC and non-DC management, and these data were too limited and heterogeneous for firm inference. Definitions of “early” and “primary” DC, patient severity, injury phenotype, use of ICP monitoring, and follow-up time points were inconsistent across studies. Conclusions The available Latin American literature on early or primary decompressive craniectomy for TBI is limited, predominantly observational, and highly heterogeneous. Reported outcomes vary markedly across studies, likely reflecting differences in case mix, treatment indication, timing, neuromonitoring, and health-system capacity. Current regional evidence remains insufficient to support firm comparative conclusions regarding the benefit of DC versus medical management. Prospective multicenter studies with standardized definitions, outcome reporting, and longer-term follow-up are needed.
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 17
CLINICAL OUTCOMES OF EARLY OR PRIMARY DECOMPRESSIVE CRANIECTOMY FOR TRAUMATIC BRAIN INJURY IN LATIN AMERICA: A SYSTEMATIC REVIEW
Background Early or primary decompressive craniectomy (DC) is widely used to treat intracranial hypertension after traumatic brain injury (TBI), yet its clinical benefit remains debated. In Latin America, outcomes may be influenced by heterogeneity in trauma systems, neurocritical care resources, neuromonitoring availability, and access to rehabilitation. Objective To systematically review the available evidence on clinical outcomes of early or primary decompressive craniectomy for adult traumatic brain injury in Latin America. Methods We conducted a systematic review in accordance with PRISMA 2020 guidance. PubMed/MEDLINE, Scopus, Embase, Web of Science, SciELO, and LILACS were searched from inception to December 10, 2025. We included studies from Latin American countries enrolling predominantly adult patients with TBI undergoing early or primary DC, with or without a medical-management comparator. Primary outcomes were favorable functional outcome (Glasgow Outcome Scale [GOS] 4–5) at hospital discharge and at approximately 6 months. Secondary outcomes included mortality at discharge among DCtreated patients and comparative mortality when a non-DC comparator was available. Given substantial clinical and methodological heterogeneity across studies, findings were synthesized narratively. Results Fourteen studies involving 1,816 patients with TBI were included, of whom 1,075 underwent early or primary DC. Most studies were retrospective observational cohorts or case series. Reported outcomes varied widely across studies. Favorable functional outcome at discharge ranged from 26% to 66% among studies reporting this endpoint, while favorable outcome at approximately 6 months ranged from 21% to 80%. Mortality at discharge among DC-treated patients also varied substantially, ranging from 0% to 61%. Only two studies reported comparative mortality between DC and non-DC management, and these data were too limited and heterogeneous for firm inference. Definitions of “early” and “primary” DC, patient severity, injury phenotype, use of ICP monitoring, and follow-up time points were inconsistent across studies. Conclusions The available Latin American literature on early or primary decompressive craniectomy for TBI is limited, predominantly observational, and highly heterogeneous. Reported outcomes vary markedly across studies, likely reflecting differences in case mix, treatment indication, timing, neuromonitoring, and health-system capacity. Current regional evidence remains insufficient to support firm comparative conclusions regarding the benefit of DC versus medical management. Prospective multicenter studies with standardized definitions, outcome reporting, and longer-term follow-up are needed.
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 29
CLINICAL CHARACTERISTICS AND OUTCOMES OF LATIN AMERICAN PATIENTS WITH ACUTE ISCHEMIC STROKE AND LARGE VESSEL OCCLUSION: A SYSTEMATIC REVIEW AND EXPLORATORY META-ANALYSIS
Background Large vessel occlusion is a major cause of stroke-related disability and death and often requires access to specialized reperfusion strategies such as mechanical thrombectomy. However, published data from Latin America remain limited and methodologically heterogeneous. This study aimed to summarize the available evidence on the characteristics, management patterns, and clinical outcomes of Latin American cohorts of patients with acute ischemic stroke (AIS) and confirmed or treatmenteligible large vessel occlusion (LVO). Methods We systematically searched six databases up to July 2024 for studies conducted in Latin American countries reporting data on adult patients with AIS and confirmed LVO, or cohorts undergoing endovascular treatment for AIS-LVO. Because many studies enrolled AIS-LVO or treatment-selected populations, the primary analytic approach was descriptive synthesis. The main outcomes were 3-month mortality and favorable functional outcome at 3 months, defined as a modified Rankin Scale (mRS) score of 0–2. For outcomes with sufficiently harmonized denominators, exploratory random-effects meta-analyses of proportions were performed. Results A total of 16 studies were included, representing 3 countries: Brazil (n = 12), Argentina (n = 2), and Chile (n = 2). Favorable functional outcome at 3 months (mRS 0–2) was reported in 11 studies, corresponding to a crude descriptive proportion of 37.7% (938/2488). Mortality at 3 months was reported in 13 studies, corresponding to a crude descriptive proportion of 19.7% (498/2533). In exploratory random-effects meta-analyses, the pooled proportion of 3-month mortality was 21.0% (95% CI 16.9%–25.7%; I² = 73.0%), while the pooled proportion of favorable functional outcome was 37.3% (95% CI 21.6%–56.3%; I² = 91.4%). Sensitivity analyses excluding studies with fewer than 20 participants yielded similar mortality estimates but persistent high heterogeneity for favorable functional outcome. Conclusions Among published Latin American AIS-LVO cohorts, approximately one in five patients died by 3 months, whereas functional independence was achieved in a smaller and substantially more heterogeneous proportion of patients. These findings should be interpreted cautiously given the variability in study design, patient selection, denominator definitions, and outcome reporting across studies.
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 29
CLINICAL CHARACTERISTICS AND OUTCOMES OF LATIN AMERICAN PATIENTS WITH ACUTE ISCHEMIC STROKE AND LARGE VESSEL OCCLUSION: A SYSTEMATIC REVIEW AND EXPLORATORY META-ANALYSIS
Background Large vessel occlusion is a major cause of stroke-related disability and death and often requires access to specialized reperfusion strategies such as mechanical thrombectomy. However, published data from Latin America remain limited and methodologically heterogeneous. This study aimed to summarize the available evidence on the characteristics, management patterns, and clinical outcomes of Latin American cohorts of patients with acute ischemic stroke (AIS) and confirmed or treatmenteligible large vessel occlusion (LVO). Methods We systematically searched six databases up to July 2024 for studies conducted in Latin American countries reporting data on adult patients with AIS and confirmed LVO, or cohorts undergoing endovascular treatment for AIS-LVO. Because many studies enrolled AIS-LVO or treatment-selected populations, the primary analytic approach was descriptive synthesis. The main outcomes were 3-month mortality and favorable functional outcome at 3 months, defined as a modified Rankin Scale (mRS) score of 0–2. For outcomes with sufficiently harmonized denominators, exploratory random-effects meta-analyses of proportions were performed. Results A total of 16 studies were included, representing 3 countries: Brazil (n = 12), Argentina (n = 2), and Chile (n = 2). Favorable functional outcome at 3 months (mRS 0–2) was reported in 11 studies, corresponding to a crude descriptive proportion of 37.7% (938/2488). Mortality at 3 months was reported in 13 studies, corresponding to a crude descriptive proportion of 19.7% (498/2533). In exploratory random-effects meta-analyses, the pooled proportion of 3-month mortality was 21.0% (95% CI 16.9%–25.7%; I² = 73.0%), while the pooled proportion of favorable functional outcome was 37.3% (95% CI 21.6%–56.3%; I² = 91.4%). Sensitivity analyses excluding studies with fewer than 20 participants yielded similar mortality estimates but persistent high heterogeneity for favorable functional outcome. Conclusions Among published Latin American AIS-LVO cohorts, approximately one in five patients died by 3 months, whereas functional independence was achieved in a smaller and substantially more heterogeneous proportion of patients. These findings should be interpreted cautiously given the variability in study design, patient selection, denominator definitions, and outcome reporting across studies.
- Open Access
- 20 February 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 111
Moyamoya disease in Latin America: A systematic literature review with an illustrative case
Background: Moyamoya disease (MMD) is a rare cerebrovascular disorder involving progressive stenosis of the internal carotid arteries and abnormal collateral vessel formation. While more prevalent in East Asia, MMD also affects Latin American populations, where clinical features and outcomes are less well defined. This study provides a systematic review of MMD in Latin America, complemented by an illustrative case. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Embase, and Scopus were searched for case reports, series, and cohort studies involving Latin American patients. Data on demographics, clinical presentation, diagnostics, treatments, and outcomes were extracted. Risk of bias was assessed using the Joanna Briggs Institute checklist. Results: Twenty-one studies comprising 47 patients from Brazil, Mexico, Colombia, Cuba, and Peru were included. Ischemic strokes were the most frequent presentation (78%), followed by hemorrhagic events (22%). Digital subtraction angiography (DSA) was the most frequently used diagnostic tool. Treatments ranged from medical therapy to surgical revascularization, mainly encephaloduroarteriosynangiosis. Across studies, most patients showed favorable outcomes, particularly those undergoing surgical intervention, while neurological sequelae were reported in a subset of cases. Conclusion: In Latin America, MMD mainly presents with ischemic symptoms and is typically diagnosed through DSA. Surgical revascularization appears to be associated with improved outcomes. The rarity and heterogeneity of cases highlight the need for further research to better characterize the disease, optimize management, and enhance patient care in the region.
- 20 February 2026
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 17, 111
Open AccessMoyamoya disease in Latin America: A systematic literature review with an illustrative case
Background: Moyamoya disease (MMD) is a rare cerebrovascular disorder involving progressive stenosis of the internal carotid arteries and abnormal collateral vessel formation. While more prevalent in East Asia, MMD also affects Latin American populations, where clinical features and outcomes are less well defined. This study provides a systematic review of MMD in Latin America, complemented by an illustrative case. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Embase, and Scopus were searched for case reports, series, and cohort studies involving Latin American patients. Data on demographics, clinical presentation, diagnostics, treatments, and outcomes were extracted. Risk of bias was assessed using the Joanna Briggs Institute checklist. Results: Twenty-one studies comprising 47 patients from Brazil, Mexico, Colombia, Cuba, and Peru were included. Ischemic strokes were the most frequent presentation (78%), followed by hemorrhagic events (22%). Digital subtraction angiography (DSA) was the most frequently used diagnostic tool. Treatments ranged from medical therapy to surgical revascularization, mainly encephaloduroarteriosynangiosis. Across studies, most patients showed favorable outcomes, particularly those undergoing surgical intervention, while neurological sequelae were reported in a subset of cases. Conclusion: In Latin America, MMD mainly presents with ischemic symptoms and is typically diagnosed through DSA. Surgical revascularization appears to be associated with improved outcomes. The rarity and heterogeneity of cases highlight the need for further research to better characterize the disease, optimize management, and enhance patient care in the region.
- 30 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , e14
In Reply: Risk Factors Associated With Seizure After Treatment of Chronic Subdural Hemorrhage: A Systematic Review and Meta-Analysis
- 30 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , e14
In Reply: Risk Factors Associated With Seizure After Treatment of Chronic Subdural Hemorrhage: A Systematic Review and Meta-Analysis
- 25 July 2025
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (10) , 839-843
Spatial-in-Spatial: The Utility of Combining Fluorescence-Guided Multiple Sampling with Spatial-Omics in Human Glioblastoma
Human glioblastoma (GBM) is a remarkable example of a highly aggressive and untreatable tumor. A formidable challenge in treating GBM is its extensive intratumor heterogeneity, which traditional bulk tissue analysis fails to capture. Fluorescence-guided multiple sampling, utilizing 5-aminolevulinic acid for tumor visualization, offers objective tumor tissue identification and enhanced spatial resolution. In this study, we present a perspective on a novel “spatial-in-spatial” approach that enables comprehensive analysis of tumor areas and their microenvironment—at macroscopic and microscopic levels—by combining fluorescence-guided multiple sampling with spatial-omics technologies. This perspective discusses how this integrated methodology has the potential to advance our understanding of GBM biology through the high-resolution, multidimensional characterization of tumor heterogeneity and identification of novel, area-specific therapeutic targets.
- 25 July 2025
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (10) , 839-843
Spatial-in-Spatial: The Utility of Combining Fluorescence-Guided Multiple Sampling with Spatial-Omics in Human Glioblastoma
Human glioblastoma (GBM) is a remarkable example of a highly aggressive and untreatable tumor. A formidable challenge in treating GBM is its extensive intratumor heterogeneity, which traditional bulk tissue analysis fails to capture. Fluorescence-guided multiple sampling, utilizing 5-aminolevulinic acid for tumor visualization, offers objective tumor tissue identification and enhanced spatial resolution. In this study, we present a perspective on a novel “spatial-in-spatial” approach that enables comprehensive analysis of tumor areas and their microenvironment—at macroscopic and microscopic levels—by combining fluorescence-guided multiple sampling with spatial-omics technologies. This perspective discusses how this integrated methodology has the potential to advance our understanding of GBM biology through the high-resolution, multidimensional characterization of tumor heterogeneity and identification of novel, area-specific therapeutic targets.
- Open Access
- 20 June 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (08) , 001-008
Corticotherapy versus adrenocorticotropic hormone for treating West syndrome: a systematic review and meta-analysis
Although it is known that the most commonly used therapies for West syndrome (WS) are intramuscular adrenocorticotropic hormone (ACTH) and oral prednisolone, there is still controversy in the literature regarding the equivalence of their effects.We aimed to present an updated review comparing the therapeutic and adverse effects of ACTH therapy versus corticosteroids in children with West syndrome (WS).The PubMed, EMBASE, and Cochrane Central databases were searched. The outcomes of interest selected were spasm cessation on day 14 of therapy, cessation of hypsarrhythmia and adverse effects such as weight gain, infection, irritability, and hypertension. Studies were reviewed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and a meta-analysis was performed. We compared the results using the risk ratio (RR) and odds ratio (OR). for the binary outcomes, with 95% confidence intervals (CI) and a random-effects model. Statistical analysis was performed using RevMan 5.1.7.Compared with corticoids, ACTH was associated with a significant increase in weight (RR: 1.41; 95% CI: 1.01–1.97; p = 0.04). There was no significant difference in cessation of spasms on day 14 (OR: 0.91; 95% CI: 0.47–1.47; p = 0.79), hypsarrhythmia (OR: 0.97; 95% CI: 0.22–4.34), irritability (RR: 0.78; 95% CI: 0.30–1.99), hypertension (RR: 0.64; 95% CI: 0.35–1.15; p = 0.14), and infection (RR: 0.69; 95% CI: 0.19–2.50; p = 0.57).This study provides robust evidence regarding the safety and efficacy of ACTH or corticoids in children with WS. However, the significant heterogeneity between studies restricts the analysis, emphasizing the need for additional research to assess the best WS treatment option.
- 20 June 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (08) , 001-008
Open AccessCorticotherapy versus adrenocorticotropic hormone for treating West syndrome: a systematic review and meta-analysis
Although it is known that the most commonly used therapies for West syndrome (WS) are intramuscular adrenocorticotropic hormone (ACTH) and oral prednisolone, there is still controversy in the literature regarding the equivalence of their effects.We aimed to present an updated review comparing the therapeutic and adverse effects of ACTH therapy versus corticosteroids in children with West syndrome (WS).The PubMed, EMBASE, and Cochrane Central databases were searched. The outcomes of interest selected were spasm cessation on day 14 of therapy, cessation of hypsarrhythmia and adverse effects such as weight gain, infection, irritability, and hypertension. Studies were reviewed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and a meta-analysis was performed. We compared the results using the risk ratio (RR) and odds ratio (OR). for the binary outcomes, with 95% confidence intervals (CI) and a random-effects model. Statistical analysis was performed using RevMan 5.1.7.Compared with corticoids, ACTH was associated with a significant increase in weight (RR: 1.41; 95% CI: 1.01–1.97; p = 0.04). There was no significant difference in cessation of spasms on day 14 (OR: 0.91; 95% CI: 0.47–1.47; p = 0.79), hypsarrhythmia (OR: 0.97; 95% CI: 0.22–4.34), irritability (RR: 0.78; 95% CI: 0.30–1.99), hypertension (RR: 0.64; 95% CI: 0.35–1.15; p = 0.14), and infection (RR: 0.69; 95% CI: 0.19–2.50; p = 0.57).This study provides robust evidence regarding the safety and efficacy of ACTH or corticoids in children with WS. However, the significant heterogeneity between studies restricts the analysis, emphasizing the need for additional research to assess the best WS treatment option.